Journal Watch - Residual Kidney Function
Incremental PD may preserve residual kidney function longer
A single-center observational study in Korea followed 347 patients; half started full-dose PD and half started incremental PD. While patient, technique, and peritonitis-free survival were similar between groups, the incremental PD group had a significantly lower risk of losing all of their kidney function (anuria).
Read the abstract » | (added 07/15/2019)
Higher Serum Albumin May Protect Residual Kidney Function in PD
In a prospective study of 104 new PD patients, having low serum albumin levels was independently associated with complete RKF loss (<100 mL/day of urine).
Read the abstract » | (added 06/13/2019)
Mycophenolate Mofetil (MMF) and Residual Kidney Function in PD
A small randomized controlled trial of people on PD (N=60) looked at whether the immune-suppressing drug mycophenolate mofetil could help protect residual kidney function. After a year, those who received MMF had significantly higher urine volume and urine Kt/V than controls, with no serious complications.
Read the abstract » | (added 12/14/2017)